GSK

Published 21, November 2023 at 1737 × 1738 in GSK and University of Oxford Launch Cancer Prevention Research Program with £50 Million Investment

GSK Achieves Landmark NMPA Approval for Shingrix as First Shingles Vaccine for Immunosuppressed Patients in China

GSK Achieves Landmark NMPA Approval for Shingrix as First Shingles Vaccine for Immunosuppressed Patients in China

Bookmark the permalink.

Comments are closed.